CA3244798A1 — Compounds and compositions for neurodegenerative diseases
Assigned to Universidade Nova de Lisboa · Expires 2023-08-24 · 3y expired
What this patent protects
The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in the prevention or treatment of a neurodegenerative disease. Furthermore, the present invention relates to the non-therapeutic use of said compounds for maintaining…
USPTO Abstract
The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof for use in the prevention or treatment of a neurodegenerative disease. Furthermore, the present invention relates to the non-therapeutic use of said compounds for maintaining and/or improving neurological and/or brain function, preferably as a food or nutraceutical composition.
Drugs covered by this patent
- Lorbrena (lorlatinib) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.